EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human CD4 T cells are a functional target for lipid nanoparticle-based mRNA vaccines

Samuel C Kim iD, Jiin Felgner, Mariella S Soto, Lauren Hitchcock, Emily K Silzel, Haven Beares, Michael J Hwang, Timothy B Yates, Siyuan Cheng, Erika M Joloya, Suhas Sureshchandra, Andrew M Sorn und 7 weitere

mBio · 12.11.2025 · 16 (11)

DOI: 10.1128/mbio.02254-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 12.11.2025. Verfasst von Samuel C Kim und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology & Biophysics, University of California Irvine, Irvine, California, USA. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, COVID-19 Vaccines, Nanoparticles, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Billions of mRNA-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lipid nanoparticle (LNP) vaccine doses have been administered globally and shown to be both safe and effective. However, the mechanisms by which mRNA vaccines facilitate protection remain unclear. Peripheral blood analyses from vaccinated individuals show B and T cell responses are elicited, but it remains unknown which cells contribute to particle uptake and protein expression to elicit protective immunity. Using mRNA LNP fluorescent reporters, we show that CD4 T cells are an unexpected target for LNP-based protein expression in vitro and in vivo . CD4 T cells transfected with commercial SARS-CoV-2 mRNA vaccines are sufficient as the sole antigen producer to generate specific antibody responses but cannot support antigen presentation to other CD4 T cells. This study demonstrates that non-antigen-presenting immune cells are a novel target for mRNA-based protein expression and can support effective adaptive immune responses. IMPORTANCE In this work, we demonstrate that CD4 T cells are a major target for lipid nanoparticle (LNP) transfection in vitro and in vivo . Using a human lymph node-like organoid model, we show that CD4 T cells effectively express the corresponding protein and support a productive humoral antigen-specific vaccine response to severe acute respiratory syndrome coronavirus 2 mRNA LNPs. Similarly, lymph node CD4 T cells are a major transfection target in vivo in a murine immunization model. Overall, we conclude that cells outside of the injection site can be significant contributors to the pool of antigen production after mRNA LNP immunization. This discovery opens the door to new vaccination strategies that could target CD4 T cells directly to optimize immune responses or immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD4-Positive T-LymphocytesCOVID-19 VaccinesNanoparticlesSARS-CoV-2COVID-19LipidsHumansAnimalsMicemRNA VaccinesRNA, MessengerAntibodies, ViralFemaleVaccines, SyntheticMice, Inbred C57BLLiposomes

Stichwörter der Autor:innen

adaptive immunologylipid nanoparticlesmRNA vaccinestranslational immunology

Substanzen

COVID-19 VaccinesLipid NanoparticlesmRNA VaccinesRNA, MessengerAntibodies, ViralVaccines, SyntheticLipidsLiposomes

Autor:innen und Institutionen

  • Department of Physiology & Biophysics, University of California Irvine, Irvine, California, USA.
  • Institute for Immunology, University of California Irvine, Irvine, California, USA.
  • Center for Virus Research, University of California Irvine, Irvine, California, USA.
  • Adeline Yen Mah Vaccine Center, University of California Irvine, Irvine, California, USA.
  • Division of Infectious Diseases, University of California Irvine, Irvine, California, USA.
  • Department of Pathology and Laboratory Medicine, University of California Irvine, Orange, California, USA.

ORCID-Profile: Samuel C Kim, Lisa E Wagar

Förderung

  • NIAID NIH HHS
  • Wellcome Trust

Zitieren

APA

Kim, S. C., Felgner, J., Soto, M. S., Hitchcock, L., Silzel, E. K., Beares, H., Hwang, M. J., Yates, T. B., Cheng, S., Joloya, E. M., Sureshchandra, S., Sorn, A. M., Wagoner, Z. W., Tifrea, D., Kabeer, M., Trask, D., Othy, S., Felgner, P., & Wagar, L. E. (2025). Human CD4 T cells are a functional target for lipid nanoparticle-based mRNA vaccines. mBio, 16(11). https://doi.org/10.1128/mbio.02254-25

Vancouver

Kim SC, Felgner J, Soto MS, Hitchcock L, Silzel EK, Beares H, et al. Human CD4 T cells are a functional target for lipid nanoparticle-based mRNA vaccines. mBio. 2025;16(11). doi:10.1128/mbio.02254-25

BibTeX
@article{Kim2025,
  author = {Kim, Samuel C and Felgner, Jiin and Soto, Mariella S and Hitchcock, Lauren and Silzel, Emily K and Beares, Haven and Hwang, Michael J and Yates, Timothy B and Cheng, Siyuan and Joloya, Erika M and Sureshchandra, Suhas and Sorn, Andrew M and Wagoner, Zachary W and Tifrea, Delia and Kabeer, Mustafa and Trask, Douglas and Othy, Shivashankar and Felgner, Philip and Wagar, Lisa E},
  title = {Human CD4 T cells are a functional target for lipid nanoparticle-based mRNA vaccines},
  journal = {mBio},
  year = {2025},
  volume = {16},
  number = {11},
  doi = {10.1128/mbio.02254-25}
}
Kostenlos starten →